Correction: PCI Biotech: Mandatory notification regarding trade of shares
PCI Biotech Holding ASA (PCIB) · publisert 8. september 2022 kl. 11:58 · vis på NewsWeb
Korrigerer melding 570735
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Borkenholm AS nærstående | – | acquisition | 4 000 | 1,948 NOK | 8. september 2022 | NO0010405640 | XOSL | llm |
Vedlegg
- Skjema for melding om transaksjoner Borkenholm AS 08092022.pdf (tekst hentet ut)
Meldingstekst
Borkenholm AS has on 8 September 2022 purchased 4,000 shares in PCI Biotech
Holding ASA ("PCI Biotech") at an average price of NOK 1.948 per share.
Borkenholm AS is a related party to board member Hilde Furberg.
After the transaction, Hilde Furberg and her related parties holds 8,000 shares
in PCI Biotech.
Release updated with attachment.
This information is subject to the disclosure requirements in MAR (regulation
(EU) No. 596/2014 on market abuse) as implemented in Norway in accordance with
section 3-1 of the Securities Trading Act.